Scinai Immunotherapeutics Ltd. (SCNI) stock
SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.37−0.03 (-7.82%)
Close on Nov 17, 2026Market cap $1.29MP/E –Yield –
Scinai Immunotherapeutics total assets
Total assets on the balance sheet at the end of each period.
Scinai Immunotherapeutics's total assets was $17.18M at Jun 30, 2026. For fiscal 2025 it was $11.63M, down 13.5% from the year before. The highest annual figure on record is $32.04M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.63M | -13.5% |
| FY2024 | Dec 31, 2024 | $13.45M | -23.0% |
| FY2023 | Dec 31, 2023 | $17.47M | -35.4% |
| FY2022 | Dec 31, 2022 | $27.07M | -15.5% |
| FY2021 | Dec 31, 2021 | $32.04M | +81.0% |
| FY2020 | Dec 31, 2020 | $17.70M | -24.9% |
| FY2017 | Dec 31, 2017 | $23.56M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $17.18M | +15.6% |
| Q4 FY2025 | Dec 31, 2025 | $11.63M | -33.5% |
| Q2 FY2025 | Jun 30, 2025 | $11.84M | -40.5% |
| Q4 FY2024 | Dec 31, 2024 | $13.45M | -42.3% |
| Q2 FY2024 | Jun 30, 2024 | $14.85M | -45.1% |
| Q4 FY2023 | Dec 31, 2023 | $17.47M | -28.5% |
| Q2 FY2023 | Jun 30, 2023 | $19.90M | -37.9% |
| Q1 FY2023 | Mar 31, 2023 | $23.29M | -7.2% |
| Q4 FY2022 | Dec 31, 2022 | $27.07M | +52.9% |
| Q2 FY2022 | Jun 30, 2022 | $24.45M | +3.8% |
| Q4 FY2021 | Dec 31, 2021 | $32.04M | – |
| Q3 FY2021 | Sep 30, 2021 | $25.09M | – |
| Q4 FY2020 | Dec 31, 2020 | $17.70M | – |
| Q4 FY2017 | Dec 31, 2017 | $23.56M | – |
See a number that looks wrong?